GSK detector sounds good to Akubio
Akubio bolsters its position in acoustic detection, which uses sound to detect the interactions between molecules, by licensing a complementary technology from GlaxoSmithKline.
Akubio bolsters its position in acoustic detection, which uses sound to detect the interactions between molecules, by licensing a complementary technology from GlaxoSmithKline.
GlaxoSmithKline has secured rights to a technology, developed in partnership with US company Advaxis, could improve the effectiveness of vaccine-based treatments for cancer.
Researchers from Icelandic genomics company deCODE Genetics have discovered the first gene ever linked to ischaemic stroke, raising the hope that new drugs to treat the condition may be developed.